Proteomic Study of Urinary Stone Disease
Urinary Proteomic Profiling Using ProteinChip SELDI-TOF-MS: A Potential Means of Identifying Protein Biomarkers of Urinary Stone Formers
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
A observational or N/A phase clinical study on Calculi and Hyperoxaluria, this trial is completed. The trial is conducted by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's and has accumulated 8 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Apr 2025 — Present [monthly]
Completed
-
Jan 2025 — Apr 2025 [monthly]
Completed
-
Sep 2024 — Jan 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- The Physicians' Services Incorporated Foundation
- University of Western Ontario, Canada
For direct contact, visit the study record on ClinicalTrials.gov .